16 . December , 2017 - Saturday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Ciclopirox Lotion

Big Image
Generic Name: Ciclopirox olamine
Dosage Form: Lotion

Rx only
FOR DERMATOLOGIC USE ONLY
NOT FOR OPHTHALMIC USE

DESCRIPTION:

Ciclopirox Topical Suspension, USP 0.77% (Lotion) is for topical use.

Each gram of Ciclopirox Topical Suspension, USP 0.77% (Lotion) contains 7.7 mg of Ciclopirox (as Ciclopirox olamine) in a water miscible lotion base consisting of purified water USP, cocamide DEA, octyldodecanol NF, mineral oil USP, stearyl alcohol NF, cetyl alcohol NF, polysorbate 60 NF, myristyl alcohol NF, sorbitan monostearate NF, lactic acid USP, and benzyl alcohol NF (1%) as a preservative.

Ciclopirox Topical Suspension, USP 0.77% (Lotion) contains a synthetic, broad-spectrum, antifungal agent Ciclopirox (as Ciclopirox olamine). The chemical name is 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone, 2-aminoethanol salt.

The CAS Registry Number is 41621-49-2. The chemical structure is:

Ciclopirox Topical Suspension, USP 0.77% (Lotion) has a pH of 7.

CLINICAL PHARMACOLOGY:

Ciclopirox is a broad-spectrum, antifungal agent that inhibits the growth of pathogenic dermatophytes, yeasts, and Malassezia furfur. Ciclopirox exhibits fungicidal activity in vitro against isolates of Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis, and Candida albicans.

Pharmacokinetic studies in men with radiolabeled Ciclopirox solution in polyethylene glycol 400, showed an average of 1.3% absorption of the dose when it was applied topically to 750 cm2 on the back followed by occlusion for 6 hours. The biological half-life was 1.7 hours and excretion occurred via the kidney. Two days after application only 0.01% of the dose applied could be found in the urine. Fecal excretion was negligible. Autoradiographic studies with human cadaver skin showed that Ciclopirox penetrates into the hair and through the epidermis and hair follicles into the sebaceous glands and dermis, while a portion of the drug remains in the stratum corneum.

In vitro penetration studies in frozen or fresh excised human cadaver and pig skin indicated that the penetration of Ciclopirox Topical Suspension, USP 0.77% (Lotion) is equivalent to that of Ciclopirox Cream 0.77%. Therapeutic equivalence of cream and lotion formulations also was indicated by studies of experimentally induced guinea pig and human trichophytosis.

INDICATIONS AND USAGE:

Ciclopirox Topical Suspension, USP 0.77% (Lotion) is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; cutaneous candidiasis (moniliasis) due to Candida albicans; and tinea (pityriasis) versicolor due to Malassezia furfur.

CONTRAINDICATIONS:

Ciclopirox Topical Suspension, USP 0.77% (Lotion) is contraindicated in individuals who have shown hypersensitivity to any of its components.

WARNINGS:

General: Ciclopirox Topical Suspension, USP 0.77% (Lotion) is not for ophthalmic use. Keep out of reach of children.

PRECAUTIONS:

If a reaction suggesting sensitivity or chemical irritation should occur with the use of Ciclopirox Topical Suspension, USP 0.77% (Lotion), treatment should be discontinued and appropriate therapy instituted.

Information for Patients

The patient should be told to:

  1. Use the medication for the full treatment time even though signs/symptoms may have improved and notify the physician if there is no improvement after four weeks.
  2. Inform the physician if the area of application shows signs of increased irritation (redness, itching, burning, blistering, swelling, oozing) indicative of possible sensitization.
  3. Avoid the use of occlusive wrappings or dressings.

Carcinogenesis, Mutagenesis, Impairment of Fertility: A carcinogenicity study in female mice dosed cutaneously twice per week for 50 weeks followed by a 6-month drug free observation period prior to necropsy revealed no evidence of tumors at the application site. The following in vitro and in vivo genotoxicity tests have been conducted with Ciclopirox olamine: studies to evaluate gene mutation in the Ames Salmonella I Mammalian Microsome Assay (negative) and Yeast Saccharomyces Cerevisiae Assay (negative); and studies to evaluate chromosome aberrations in vivo in the Mouse Dominant Lethal Assay, and in the Mouse Micronucleus Assay at 500 mg/kg (negative). The following battery of in vitro genotoxicity tests were conducted with Ciclopirox: a chromosome aberration assay in V79 Chinese Hamster Cells, with and without metabolic activation (positive); a gene mutation assay in the HGPRT - test with V79 Chinese Hamster Cells (negative); and a primary DNA damage assay (i.e., unscheduled DNA Synthesis Assay in A549 Human Cells (negative)). An in vitro Cell Transformation Assay in BALB/C3T3 Cells was negative for cell transformation. In an in vivo Chinese Hamster Bone Marrow Cytogenetic Assay, Ciclopirox was negative for chromosome aberrations at 5000 mg/kg.

Pregnancy Category B. Reproduction studies have been performed in the mouse, rat, rabbit, and monkey, via various routes of administration, at doses 10 times or more the topical human dose and have revealed no significant evidence of impaired fertility or harm to the fetus due to Ciclopirox. There are, however, no adequate or well controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Nursing Mothers: It is not known whether this drug is excreted in human milk. Caution should be exercised when Ciclopirox Topical Suspension, USP 0.77% (Lotion) is administered to a nursing woman.

Pediatric Use: Safety and effectiveness in pediatric patients below the age of 10 years have not been established.

ADVERSE REACTIONS:

In the controlled clinical trial with 89 patients using Ciclopirox Topical Suspension, USP 0.77% (Lotion) and 89 patients using the lotion vehicle, the incidence of adverse reactions was low. Those considered possibly related to treatment or occurring in more than one patient were pruritus, which occurred in two patients using Ciclopirox Topical Suspension, USP 0.77% (Lotion) and one patient using the lotion vehicle; and burning, which occurred in one patient using Ciclopirox Topical Suspension, USP 0.77% (Lotion).

DOSAGE AND ADMINISTRATION:

Gently massage Ciclopirox Topical Suspension, USP 0.77% (Lotion) into the affected and surrounding skin areas twice daily, in the morning and evening. Clinical improvement with relief of pruritus and other symptoms usually occurs within the first week of treatment. If a patient shows no clinical improvement after four weeks of treatment with Ciclopirox Topical Suspension, USP 0.77% (Lotion) the diagnosis should be redetermined. Patients with tinea versicolor usually exhibit clinical and mycological clearing after two weeks of treatment.

HOW SUPPLIED:

Ciclopirox Topical Suspension, USP 0.77% (Lotion) is supplied in:

 
30 mL bottles (NDC 0168-0314-30)
 
60 mL bottles (NDC 0168-0314-60)

Bottle space provided to allow for vigorous shaking before each use.
Store between 5°-25°C (41°-77°F).

E. FOUGERA & CO.
a division of Altana Inc.
MELVILLE, NEW YORK 11747

I2314/IF2314
R6/04
#218


Ciclopirox (Ciclopirox)
PRODUCT INFO
Product Code 0168-0314 Dosage Form LOTION
Route Of Administration TOPICAL DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Ciclopirox olamine (Ciclopirox) Active 7.7 MILLIGRAM  In 1 MILLILITER
water Inactive  
cocamide DEA Inactive  
octyldodecanol Inactive  
mineral oil Inactive  
stearyl alcohol Inactive  
cetyl alcohol Inactive  
polysorbate 60 Inactive  
myristyl alcohol Inactive  
sorbitan monostearate Inactive  
lactic acid Inactive  
benzyl alcohol Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0168-0314-30 30 MILLILITER In 1 BOTTLE None
2 0168-0314-60 60 MILLILITER In 1 BOTTLE None

Revised: 10/2006

Recent Drug Updates at DrugIndexOnline:





carteolol carteolol
Generic Name: carteolol (KAR tee oh lole) Brand Names: Cartrol What is carteolol? Carteolol is in a group of drugs called beta-blockers. Beta-blockers affect the heart and circulation (blood flow through arteries and veins). Carteolol is used to treat hypertension (high blood pressure). more...

Cascara Sagrada Cascara Sagrada
Generic Name: Cascara Sagrada Capsules (kass-KA-rah sah-GRAH-dah) Brand Name: Generic only. No brands available.Cascara Sagrada is used for:Relieving occasional constipation (irregularity). Cascara Sagrada is a stimulant laxative. Exactly how Cascara Sagrada works is unknown, but it may work b more...

Cefaclor Cefaclor
Generic name: Cefaclor Brand names: Ceclor Why is Cefaclor prescribed? Ceclor, a cephalosporin antibiotic, is used in the treatment of ear, nose, throat, respiratory tract, urinary tract, and skin infections caused by specific bacteria, including staph, strep, and E. coli. Uses include treatment more...

chlorpheniramine and dextromethorphan chlorpheniramine and dextromethorphan
Generic Name: chlorpheniramine and dextromethorphan (klor feh NEER a meen and dex troe meh THOR fan) Brand Names: Coricidin Cough and Cold, Effective Strength Cough Syrup, Primatuss 4, Scot-Tussin Sugar Free DM, Tricodene Sugar Free What is chlorpheniramine and dextromethorphan? Chlorphe more...

Daunorubicin, Liposomal Daunorubicin, Liposomal
Some commonly used brand names are: In the U.S.— DaunoXome † Not commercially available in Canada. Category Antineoplastic Description Liposomal daunorubicin (LIP-oh-som-al daw-noe-ROO-bi-sin) belongs to the general group of medicines known as antineoplastics. It is used t more...

Fleet Soflax Gelcaps Fleet Soflax Gelcaps
Some commonly used brand names are: In the U.S.— Agoral 35 Alophen 25 Alphamul 30 Alramucil Orange 7 Alramucil Regular 7 Bisac-Evac 25 Black-Draught 26 Black-Draught Lax-Senna 32 Carter's Little Pills 25 Cholac 14 Citroma 16 Citrucel Orange Flavor 3 Citrucel Sugar-Free Orange Flavor 3 Col more...

methsuximide methsuximide
Generic Name: methsuximide (meth SUX i mide) Brand Names: Celontin What is methsuximide? Methsuximide is an anticonvulsant. It works by slowing down impulses in the brain that cause seizures. Methsuximide is used to treat absence or "petit mal" seizures that have not responded to other a more...

Onguent de Calamine Topical Onguent de Calamine Topical
Some commonly used brand names are: In the U.S.— Calamox In Canada— Diaper Rash Ointment Onguent de Calamine Generic name product may be available in the U.S. and Canada. Category Antipruritic, topical Skin protectant Description Calamine (KAL-a-meen) is used to relieve t more...